Detail Information of Genetic Polymorphisms
| General Information of Drug Transporter (DT) | |||||
|---|---|---|---|---|---|
| DT ID | DTD0267 Transporter Info | ||||
| Gene Name | SLC2A9 | ||||
| Protein Name | Glucose transporter type 9 | ||||
| Gene ID | |||||
| UniProt ID | |||||
| Genetic Polymorphisms of DT (GPD) | |||||
| Genetic Polymorphism | rs3733591 | ||||
| Site of GPD | chr4:9920506 (GRCh38.p12) | ||||
| GPD Type | SNP | ||||
| Allele(s) in dbSNP | C>T | ||||
| Minor Allele Frequency | T=0.1494/1943 (Global) | ||||
| Allele C | Click to Show/Hide the Full List of Affected Drugs: 1 Drugs in Total | ||||
| N.A. | N.A. | Gout | Correlated with the increased gout susceptibility (compare with allele T) | [ 1] | |
| Genetic Polymorphism | rs12510549 | ||||
| Site of GPD | chr4:10274843 (GRCh38.p12) | ||||
| GPD Type | SNP | ||||
| Allele(s) in dbSNP | T>C | ||||
| Minor Allele Frequency | C=0.1673/838 (Global) | ||||
| Allele C | Click to Show/Hide the Full List of Affected Drugs: 1 Drugs in Total | ||||
| N.A. | N.A. | Gout | Correlated with the protected against the development of gout (compare with allele T) | [ 2] | |
| Genetic Polymorphism | rs16890979 | ||||
| Site of GPD | chr4:9920543 (GRCh38.p12) | ||||
| GPD Type | SNP | ||||
| Allele(s) in dbSNP | C>T | ||||
| Minor Allele Frequency | T=0.1855/831 (Global) | ||||
| Allele T | Click to Show/Hide the Full List of Affected Drugs: 1 Drugs in Total | ||||
| N.A. | N.A. | Gout | Correlated with the risk for gout (compare with allele C) | [ 1] | |
| Genetic Polymorphism | rs1014290 | ||||
| Site of GPD | chr4:10000237 (GRCh38.p12) | ||||
| GPD Type | SNP | ||||
| Allele(s) in dbSNP | G>A | ||||
| Minor Allele Frequency | G=0.2281/1022 (Global) | ||||
| Allele C | Click to Show/Hide the Full List of Affected Drugs: 1 Drugs in Total | ||||
| N.A. | N.A. | Gout | Correlated with the risk for gout (compare with allele T) | [ 1] | |
| Genetic Polymorphism | rs11942223 | ||||
| Site of GPD | chr4:9961141 (GRCh38.p12) | ||||
| GPD Type | SNP | ||||
| Allele(s) in dbSNP | T>C | ||||
| Minor Allele Frequency | T=0.7350/1454 (Global) | ||||
| Allele T | Click to Show/Hide the Full List of Affected Drugs: 1 Drugs in Total | ||||
| Allopurinol | N.A. | Diabetes Mellitus | Allele T is not associated with dose of allopurinol in people with Gout as compared to allele C. | [ 3] | |
| Allele C | Click to Show/Hide the Full List of Affected Drugs: 1 Drugs in Total | ||||
| Furosemide | N.A. | Diabetes Mellitus | Allele C is not associated with response to furosemide in healthy individuals as compared to allele T. | [ 4] | |
| References | |||||
| 1 | Association between SLC2A9 (GLUT9) gene polymorphisms and gout susceptibility: an updated meta-analysis. Rheumatol Int. 2016 Aug;36(8):1157-65. | ||||
| 2 | Associations between SLC2A9 polymorphisms and gout susceptibility : A meta-analysis. Z Rheumatol. 2017 Feb;76(1):64-70. | ||||
| 3 | The impact of diuretic use and ABCG2 genotype on the predictive performance of a published allopurinol dosing tool. Br J Clin Pharmacol. 2018 May;84(5):937-943. | ||||
| 4 | Influence of genetic variants on renal uric acid handling in response to frusemide: an acute intervention study. RMD Open. 2017;3(1):e000424. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.